Switching insulin regimens after intensive therapy for type 2 diabetes
Effectiveness of Regimen Switch After Intensive Insulin Therapy in Hospitalized Patients With Type 2 Diabetes
This study looks at how and when to change diabetes treatments for people with type 2 diabetes who have just finished intensive insulin therapy in the hospital.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Shanghai Zhongshan Hospital Academic / other |
| Locations | 2 sites (Shanghai, Shanghai and 1 other locations) |
| Trial ID | NCT04833413 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on patients with type 2 diabetes who have undergone intensive insulin therapy during hospitalization. It aims to explore the timing and methods for switching to other treatment regimens after initial insulin therapy, considering factors such as glycemic control, patient compliance, and diabetes complications. Data will be collected on various patient characteristics and follow-ups will occur at specified intervals to assess treatment adjustments. The goal is to establish guidelines for transitioning from intensive insulin therapy to alternative treatments.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older with type 2 diabetes who have started intensive insulin therapy during hospitalization.
Not a fit: Patients with type 1 diabetes, acute diabetes complications, severe infections, or those who are pregnant may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide clearer guidelines for managing type 2 diabetes after intensive insulin therapy, potentially improving patient outcomes.
How similar studies have performed: While there may be limited studies specifically addressing regimen switching after intensive insulin therapy, the approach of optimizing diabetes management post-insulin therapy has shown promise in related research.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with type 2 diabetes; * Patients who started intensive insulin therapy during hospitalization * Age ≥18 years old Exclusion Criteria: * Type 1 diabetes, special type diabetes * Acute complications of diabetes (diabetic ketoacidosis, hyperglycemia and hyperosmolarity) * Severe infection * pregnancy or planned pregnancy * Participating in other clinical studies or trials
Where this trial is running
Shanghai, Shanghai and 1 other locations
- Zhongshan hospital — Shanghai, Shanghai, China (Not_yet_recruiting)
- Department of Endocrinoogy, Zhongshan Hospital Fudan University — Shanghai, China (Recruiting)
Study contacts
- Study coordinator: Xiao ying Li, MD
- Email: xiaoying_li@hotmail.com
- Phone: 13651913857
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.